Article Text

Download PDFPDF
Positive benefit of postnatal treatment in congenital toxoplasmosis
  1. J E Gomez-Marin,
  2. A delaTorre
  1. Centro de Investigaciones Biomedicas, Universidad del Quindio, Quindio, Colombia
  1. Correspondence to:
    J E Gomez-Marin
    Centro de Investigaciones Biomedicas, Universidad del Quindio, Quindio, Colombia; gepamol2{at}uniquindio.edu.co

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read the editorial of Gilbert and Desateux.1 In their analysis, they take into account some newborn screening programmes for congenital toxoplasmosis in developing countries such as Brazil and Mexico, with reported rates of up to a maximum of 20 cases/10 000 live births; however, they did not mention our recent report that found a prevalence of 0.5% in a reference hospital in Colombia.2 This study found one child who died 1 week after birth. As we had information only on the frequency of deaths in a reference hospital, we carried out a study in a representative sample of all newborns from Quindio and found nearly the same prevalence: 0.6% (see letter in Archives of Disease in Children in response to the paper …

View Full Text

Footnotes

  • Competing interests: None declared.